TuHURA Biosciences

HURANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$135.738 M

$2.13 -2.29%

Close of 22 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$31.0M

Loss-making

Shares outstanding

63,726,617

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#289MedicinovaMNOV$142.7M
#290Unicycive TherapeuticsUNCY$138.2M
#291TuHURA BiosciencesHURA$135.7M
#292Inovio PharmaceuticalsINO$133.4M
#293Aardvark TherapeuticsAARD$125.8M

What if TuHURA Biosciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$474,432.37

Per share 222,738× higher

Bitcoin $1.74T

$27,330.10

Per share 12,831× higher

Nvidia $5.52T

$86,553.58

Per share 40,635× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for TuHURA Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.